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Objective: Neonates undergoing cardiac surgery have a systemic inflammatory
reaction with release of proinflammatory cytokines, which could be responsible for
myocardial dysfunction as a result of myocardial cell damage. The purpose of this
study was to test the hypothesis that the production of proinflammatory cytokines
during cardiac surgery would be associated with myocardial dysfunction after the
arterial switch operation in neonates.
Methods: A total of 63 neonates with transposition of the great arteries were
operated on with combined deep hypothermic circulatory arrest and low-flow
cardiopulmonary bypass at a median age of 7 days. Perioperative plasma concen-
trations of interleukins 6 and 8 were correlated with myocardial dysfunction, as
assessed clinically and by echocardiography within 24 hours after the operation, and
with perioperative cardiac troponin T blood levels as a marker of myocardial cell
damage.
Results: Myocardial dysfunction was observed in 11 patients (17.5%), and 2 of them
died. Durations of cardiopulmonary bypass and aortic crossclamping, but not of
circulatory arrest, were correlated with myocardial dysfunction. Patients with myo-
cardial dysfunction had significantly higher cardiac troponin T blood levels at the
end of cardiopulmonary bypass and 4 and 24 hours after the operation than did
patients without myocardial dysfunction. Patients with myocardial dysfunction also
had higher interleukin 6 plasma concentrations after cardiopulmonary bypass and 4
hours after the operation, as well as higher interleukin 8 plasma concentrations 4 and
24 hours after the operation, than did those without myocardial dysfunction. Post-
operative interleukin 6 and 8 plasma concentrations were significantly correlated
with postoperative cardiac troponin T blood levels. Multivariable analysis of inde-
pendent risk factors for myocardial dysfunction comprising cytokine and troponin
levels and bypass duration revealed interleukin 6 levels 4 hours after the operation
as significant (P  .047).
Conclusions: Cardiac operations in neonates stimulate the production of proinflam-
matory cytokines, which may contribute to myocardial cell damage and myocardial
dysfunction.
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Perioperative myocardial damage is an impor-tant factor influencing postoperative courseand hemodynamic profile after surgery forcongenital heart disease,1-5 but its pathophys-iologic mechanisms remain unclear. The sys-temic and intramyocardial inflammatory re-
sponse has been suggested to contribute to myocardial
dysfunction.6,7
Term neonates undergoing cardiac surgery have a sys-
temic inflammatory reaction comprising complement acti-
vation, leukocyte stimulation, and cytokine synthesis.8,9
Proinflammatory cytokines such as interleukin (IL) 6, the
regulator of the acute-phase response, and IL-8, a potent
chemokine with neutrophil-stimulating properties, are in-
volved in the systemic inflammatory response related to
cardiopulmonary bypass (CPB) in children.10-13 These cy-
tokines may cause myocardial cell damage and consecutive
myocardial dysfunction as a result of nitric oxide-indepen-
dent and nitric oxide-dependent pathways14-16 and as a
result of increased leukocyte-endothelial cell interactions,
with consequent capillary obstruction and impaired micro-
circulation in the myocardium.17
Although the responsibility of perioperative proinflam-
matory cytokine production for the development of postop-
erative myocardial dysfunction has been suggested in adult
patients after cardiac surgery,18-21 this question has never
been addressed in children or neonates. It was therefore the
aim of our study to test the hypothesis that proinflammatory
cytokine release during cardiac surgery in neonates is asso-
ciated with postoperative myocardial cell damage and con-
sequent myocardial dysfunction.
Methods
Clinical Data
Patients. After approval by the human ethical committee of
our institution and informed consent of the parents, 63 consecutive
term neonates aged 2 to 28 days (median 7 days, interquartile
difference 6 days) at surgery were included in this prospective
study. Patients’ demographic data are shown in Table 1. The
inclusion criterion was transposition of the great arteries, with a
ventricular septal defect (VSD) suitable for the arterial switch
operation or without (no VSD, n  53), with closure of the VSD
if necessary (VSD closure, n  10). Coronary artery status was
categorized as normal (types A1 or AB1) or abnormal (other
types), according to the classification of Gittenberger-de Groot and
associates.22 All patients received prostaglandin E1 infusion (0.05
g/[kg  min]) before the operation to maintain patency of the
ductus arteriosus. Maternofetal infection or bacterial infection
before the operation and preoperative organ dysfunction were
cause for exclusion in all cases.
Anesthesia and antibiotic regimen. Conventional general an-
esthesia was conducted with diazepam, fentanyl sulfate, and pan-
curonium bromide. After induction of anesthesia, nasotracheal
intubation was performed in the patients not receiving ventilatory
support, and central venous catheters and peripheral arterial cath-
eter were inserted. Perioperative antibiotic prophylaxis consisted
of cefotiam. Dexamethasone was given before sternotomy at a
dosage of 3 mg/m2 body surface area.
Cardiopulmonary bypass protocol. The CPB circuit included
a roller pump, a disposable membrane oxygenator, and an arterial
filter. Cooling and rewarming were carried out with a heat ex-
changer. The priming solution consisted of a crystalloid solution,
mannitol (3 mL/kg), and leukocyte-depleted packed red blood cells
to obtain a hematocrit value of the circulating volume of about
25%. Heparinization was achieved with heparin sulfate (3 mg/kg).
For vasodilatation in the cooling and rewarming periods, all neo-
nates received a continuous infusion of sodium nitroprusside
(SNP, 0.5-1 g/[kg  min]). CPB was instituted with a perfusion
index of 2.7 L/(min  m2), which was maintained throughout the
cooling phase. During CPB the pH-stat method was used, with
correction of PaO2 to the patients’s hypothermic temperature to
maintain a pH value of 7.40. After deep hypothermia was reached
(minimal nasopharyngeal temperature averaging 15°C), aortic
crossclamping was done and cardioplegia was induced with a
single intra-aortic injection of a 4°C cold Bretschneider solution
(30 mL/kg), and cardiocirculatory arrest was instituted for a target
period of not longer than 60 minutes. The surgical procedure was
continued under low-flow perfusion (25% of the calculated initial
perfusion rate). Rewarming was achieved under full-flow condi-
tions. The lungs of the neonates were reventilated when core
temperature reached 30°C. Neutralization of heparin was achieved
with protamine sulfate in a 1:1 ratio. Epinephrine, dopamine, and
SNP were systematically administered for weaning the patients
from CPB. After coronary reperfusion and at the end of the
operation, intraoperative myocardial function was assessed by the
cardiac surgeon, as explained here. In cases of hemodynamic
instability or myocardial dysfunction at the end of the operation,
sternal closure was delayed until stabilization, and sternal wounds
were closed with a latex membrane.
Perioperative and postoperative care. Postoperative monitor-
ing included continuous registration of heart rate and rhythm,
arterial blood pressure, central venous pressure, and diuresis. Tar-
get values for mean arterial blood pressure, central venous pres-
sure, and diuresis during the first 72 hours after the operation were
45 mm Hg, 5 to 7 mm Hg, and more than 1.5 mL/(kg  h),
respectively. Inotropic support, vasodilation, and diuretic treat-
ment consisting of epinephrine, dopamine, dobutamine, SNP, and
furosemide were adapted accordingly, as was volume substitution,
which was carried out with fresh-frozen plasma or 5% human
albumin. Blood gas values, serum electrolytes, serum creatinine,
aspartate aminotransferase (AST), and bilirubin were routinely
measured during the first 3 postoperative days. The ratio between
PaO2 and inspired oxygen fraction was used as oxygenation index
for patients receiving ventilatory support.
Myocardial dysfunction was considered to be hypocontractility
of one or both ventricles, as reported by the surgeon at the end of
the operation or by the pediatric cardiologist from systematic
transthoracic echocardiography 4 and 24 hours after the operation.
Repeated routine transesophageal echocardiography was not pos-
sible in most cases. The decision to delay sternal closure or
increase inotropic support was based on hemodynamic parameters,
as stated previously, and was not a criterion for assignment to the
myocardial dysfunction group.
Surgery for Congenital Heart Disease Ho¨vels-Gu¨rich et al
812 The Journal of Thoracic and Cardiovascular Surgery ● October 2002
CH
D
Myocardial ischemia was diagnosed in the presence of discol-
ored or demarcated myocardial areas seen by the surgeon after
coronary reperfusion and before the end of the operation. It was
also diagnosed on the basis of typical repolarization abnormalities
in the standard electrocardiogram 4 and 24 hours after the opera-
tion.
Total inotropic support was calculated 4 and 24 hours after the
operation by adding the doses of dopamine and dobutamine in
micrograms per kilogram per minute and assigning an arbitrary
equivalent value of 10 g/(kg  min) inotropic agent for each 0.1
g/(kg  min) epinephrine.1 Dopamine was given in a dosage of
5g/(kg  min) as basic support in all cases. Dobutamine was
administered at a dosage of 5 to 10 g/(kg  min), according to
hemodynamic need, and epinephrine was given additionally, also
according to hemodynamic need.
Specific Laboratory Examinations
Collection of samples. Venous blood was collected before and
after the operation. During CPB, blood was withdrawn from the
arterial line of the circuit. For each sample time, 1 mL blood was
taken in tubes containing ethylenediaminetetraacetic acid. The
samples were immediately centrifuged for 3 minutes (3000 rpm),
and the plasma was stored at 70°C until analysis. Plasma sam-
ples were collected before the operation, at the end of CPB after
protamine administration, and at 4 and 24 hours after the end of
CPB.
Cardiac troponin T. Cardiac troponin T (cTnT) concentration
was determined by enzyme-linked immunosorbent assay (ELISA
Troponin-T Kit; Boehringer Mannheim, Division of Roche Phar-
maceuticals, Mannheim, Germany), with the use of two highly
specific monoclonal antibodies directed against two different
epitopes of the cTnT molecule, allowing high specificity. Cross-
reactivity with skeletal muscle troponin T and the influence of
hemolysis and hyperbilirubinemia (bilirubin 25 mg/dL) were
excluded by the manufacturer. Normal values for healthy neonates
range up to 0.33 ng/mL (95th percentile according to Panteghini
and associates23).
Cytokines. IL-6 and IL-8 concentrations were measured by
immunoenzymetric assay (enzyme-amplified sensitivity immuno-
assay; BioSource Europe [formerly Medgenix Diagnosics], Niv-
elles, Belgium) according to the manufacturer’s recommendation.
This is a solid-phase enzyme-amplified sensitivity immunoassay
performed on microtiter plate that is based on the oligoclonal
system in which several monoclonal antibodies directed against
distinct epitopes of the intact cytokine are used, allowing high
sensitivity of the assay. The minimal detectable concentrations are
2 pg/mL for IL-6 and 0.7 pg/mL for IL-8. The ranges covered by
the standard curve are 0 to 2100 pg/mL for IL-6 and 0 to 750
pg/mL for IL-8. In plasma from healthy adults, values range
between 0 and 70 pg/mL for IL-6 and between 0 and 47 pg/mL for
IL-8. In cord venous and arterial blood from healthy neonates,
mean ( SEM) values are 16  2 and 40  14 pg/mL, respec-
tively, for IL-6 and 4.6  1.0 and 6.1  1.0 pg/mL, respectively,
for IL-8 according to our previous results.24
During the study period, cTnT, IL-6, and IL-8 plasma levels
were not known to the treating physicians.
Statistical Analysis
Results are expressed as the median value and interquartile range
or interquartile difference, assuming nonnormal distribution of the
data, or by their logarithmic values. For intergroup comparison of
clinical and biologic variables at specific sample times, the non-
parametric Mann-Whitney U test was used. For comparison of
biologic variables at specific sample times within a group, the
paired nonparametric Wilcoxon test was used. The Spearman rank
correlation coefficient was assessed for correlation of independent
parameters, and the Fisher exact test was used for the analysis of
contingency tables. The  adjustment for repeated measures was
done according to the Bonferroni-Holm method. For multivariable
analysis of risk factors for the occurrence of myocardial dysfunc-
tion within 24 postoperative hours, a logistic regression was per-
formed with nine independent risk factors that were statistically
significant in corresponding univariate analysis: VSD closure,
CPB duration, aortic crossclamping duration, IL-6 blood levels 4
hours after the operation, IL-8 blood levels 4 and 24 hours after the
operation, and cTnT blood levels at the end of CPB and 4 and 24
hours after the operation. Additional case-matched analysis for the
TABLE 1. Demographic data and duration of perfusion
variables related to myocardial dysfunction
Myocardial
dysfunction
(n  11; 17.5%)
No myocardial
dysfunction
(n  52; 82.5%) P value*
VSD status (No.)
VSD closure 5 5 .01
No VSD 6 47
Coronary status (No.)
Normal (types A1
and AB1)†
10 42 .2
Abnormal (other
types)†
1 10
Operative variables
Age at operation
(d, median and
interquartile
difference)
9 (8) 7 (5) .07
CPB (min, median
and interquartile
difference)
55 (41) 45 (15) .03
Aortic
crossclamping
(min, median
and interquartile
difference)
78 (26) 62 (9) .008
DHCA (min,
median and
interquartile
difference)
60 (6) 59 (4) .2
*Calculated by Fisher exact test (parametric variables) or Mann-Whitney U
test (nonparametric variables) for the effect of the demographic and
perfusion parameters, stratified for myocardial dysfunction or no myocar-
dial dysfunction.
†Coronary artery status according to Gittenberger-de Groot et al.22
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durations of CPB and aortic crossclamping was performed in order
to evaluate whether cytokine plasma levels were different in pa-
tients for whom CPB and aortic crossclamping durations were
similar but in whom myocardial dysfunction did or did not de-
velop. Statistical analysis was performed with the Statistical Anal-
ysis System, version 8.0 (SAS Institute, Inc, Cary, NC). The term
significant was used to indicate statistical, not clinical, signifi-
cance.
Results
Clinical results
Two of 63 patients (3.2%) died within the early postoper-
ative period (Table 2). Eleven neonates (17.5%) had myo-
cardial dysfunction develop within the first 24 hours after
CPB (5 patients at the end of the operation and 6 patients in
the postoperative period), according to the clinical defini-
tion given previously. Four of these neonates also had signs
of myocardial ischemia (2 of them died). In 5 cases the
sternum was left open at the end of the operation.
According to the univariate analyses, patients with myo-
cardial dysfunction had longer CPB and aortic crossclamp-
ing durations than did those without myocardial dysfunc-
tion, whereas differences in duration of deep hypothermic
cardiac arrest (DHCA) could have been due to chance
(Table 1). Patients with VSD closure had significantly
longer durations of CPB (median 75 min, interquartile dif-
ference 30 min, vs median 44 min, interquartile difference
14 min, P  .03) and of aortic crossclamping (median 82
min, interquartile difference 13 min, vs median 62 min,
interquartile difference 7 min, P  .008) than did those
without myocardial dysfunction. Myocardial dysfunction
was significantly more frequent in patients with VSD clo-
sure than in those without such closure. Age at surgery
tended to influence the occurrence of myocardial dysfunc-
tion. Differences in coronary artery status with respect to
myocardial dysfunction could have been due to chance
(Table 1).
With respect to perioperative hemodynamic data 4 and
24 hours after the operation, median arterial blood pressure,
central venous pressure, and diuresis were not different in
patients with and without myocardial dysfunction (P  .2
each; data not shown), whereas AST was significantly ele-
vated 4 and 24 hours after the operation and oxygenation
index tended to be lower 24 hours after the operation in
patients with myocardial dysfunction. Total inotropic sup-
port was significantly higher 4 and 24 hours after the oper-
ation in patients with myocardial dysfunction than in those
without myocardial dysfunction, whereas differences in
SNP dosages could have been due to chance. Delayed
sternal closure after severe intraoperative hemodynamic in-
stability was more frequent and mechanical ventilation time
was prolonged in patients with myocardial dysfunction (Ta-
ble 2).
TABLE 2. Clinical outcome data related to myocardial dysfunction
Myocardial
dysfunction
(n  11)
No myocardial
dysfunction
(n  52) P value*
AST (U/L, median and interquartile difference)
4 postoperative h 70 (98) 32 (18) .003
24 postoperative h 84 (103) 16 (15) .003
Oxygenation index† (median and interquartile difference)
4 postoperative h 140 (147) 193 (104) .2
24 postoperative h 177 (156) 220 (125) .05
Total inotropic support (g/[kg  min], median and
interquartile difference)
4 postoperative h 26.6 (42.4) 13.6 (17.3) .04
24 postoperative h 53.8 (40.1) 8.8 (14.5) .001
SNP (g/[kg  min], median and interquartile difference)
4 postoperative h 0.93 (0.61) 0.99 (0.65) .2
24 postoperative h 1.00 (0.68) 0.87 (0.40) .2
Delayed sternal closure (No.) 5 0 .001
Postoperative mechanical ventilation (h, median and
interquartile difference)
130 (70)‡ 96 (72) .04
In-hospital death (No.) 2§ 0 .02
*Calculated by Fisher exact test (parametric variables) or Mann-Whitney U test (nonparametric variables) for the effect of the outcome variables, stratified
for myocardial dysfunction or no myocardial dysfunction.
†Ratio between partial arterial oxygen tension and inspired oxygen fraction in patients with mechanical ventilation.
‡n  9.
§Patient 1, with subpulmonary VSD and normal coronary anatomy, had left ventricular infarction after coronary reperfusion and died 25 hours after the
operation. Patient 2, with large inlet-type VSD and abnormal coronary anatomy, had right ventricular infarction after coronary reperfusion and died 35 hours
after the operation.
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Cardiac Troponin T
Preoperative cTnT levels were normal in all neonates except
for two (0.4 and 0.9 ng/mL), in whom neither preoperative,
perioperative, nor postoperative complications, nor findings
of myocardial dysfunction, were present. Within the whole
group as well as within the subgroups with and without
myocardial dysfunction, cTnT levels rose significantly at
the end of CPB, reaching peak values 4 hours after the
operation (P  .001 each vs preoperative values; Figure 1).
The cTnT levels fell between 4 and 24 hours after the
operation (P .001 each). The cTnT values after CPB were
significantly correlated with those 4 and 24 hours after the
operation (Figure 2); cTnT values after CPB, 4 and 24 hours
after the operation were correlated with durations of CPB
and aortic crossclamping but not DHCA (Table 3). Inter-
group comparison between patients with and without myo-
cardial dysfunction showed significantly higher cTnT levels
in patients with myocardial dysfunction at the end of CPB
and 4 and 24 hours after the operation than in those without
myocardial dysfunction (Figure 1).
Interleukin 6
In all neonates, preoperative IL-6 levels were not markedly
elevated relative to either normal adult or cord blood values.
Within the whole group, as well as within the subgroups
with and without myocardial dysfunction, IL-6 levels rose
significantly at the end of CPB; peak levels were reached 4
hours after the operation in patients with myocardial dys-
function and 24 hours after the operation in patients without
myocardial dysfunction (P  .001 each vs preoperative
values; Figure 3). IL-6 values after CPB were correlated
with durations of CPB, aortic crossclamping, and DHCA
(Table 3). Significant correlations were found between IL-6
and cTnT levels after CPB (Spearman correlation coeffi-
cient 0.32, P  .02). Intergroup comparison between pa-
tients with and without myocardial dysfunction showed that
IL-6 levels tended to be higher at the end of CPB and were
significantly higher 4 hours after the operation in patients
with myocardial dysfunction than in those without myocar-
dial dysfunction (Figure 3).
Interleukin 8
In all neonates, preoperative IL-8 levels were not markedly
elevated relative to either normal adult or cord blood values.
Within the whole group, as well as within the subgroups
with and without myocardial dysfunction, IL-8 levels rose
significantly at the end of CPB, reaching peak values 4
hours after the operation (P  .001 each vs preoperative
values; Figure 4), and decreased 24 hours after the opera-
tion. IL-8 values after CPB were correlated with durations
of CPB, aortic crossclamping, and DHCA (Table 3). Sig-
nificant correlations were found between IL-8 and cTnT
levels 4 hours after the operation (Spearman correlation
coefficient 0.34, P  .02), between IL-8 levels 4 hours after
the operation and cTnT levels 24 hours after the operation
(Spearman correlation coefficient 0.46, P  .001), and
between IL-8 levels and cTnT levels 24 hours after the
operation (Spearman correlation coefficient 0.43, P .003).
Intergroup comparison between patients with and without
myocardial dysfunction showed significantly higher IL-8
Figure 1. Concentrations of cTnT related to presence (white bars, n  11) and absence (shaded bars, n  52) of
myocardial dysfunction after CPB in 63 patients. Values expressed as mean (data points), median (horizontal lines),
interquartile ranges (bars), and 10th and 90th percentiles (error bars). P values represent differences between
subgroups with and without myocardial dysfunction.
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levels in patients with myocardial dysfunction 4 and 24
hours after the operation than in those without myocardial
dysfunction (Figure 4).
Multivariable Analysis
Multivariable analysis of independent risk factors for the
occurrence of myocardial dysfunction within 24 hours after
the operation was performed with nine parameters (VSD
closure, CPB duration, aortic crossclamping duration, IL-6
blood levels 4 hours after the operation, IL-8 blood levels 4
and 24 hours after the operation, and cTnT blood levels at
the end of CPB and 4 and 24 hours after the operation),
according to the model described previously. IL-6 plasma
concentration 4 hours after the operation was evaluated as
significant for prediction of myocardial dysfunction within
24 hours after the operation (P  .047, odds ratio per 10
pg/mL 1.241, 95% confidence interval, 1.002-1.535). The
cutoff point for prediction of myocardial dysfunction was
set at 500 pg/mL (specificity 95.4%, sensitivity 72.7%).
Additional case-matched analysis for the durations of
TABLE 3. Concentration of cTnT, IL-6, and IL-8 related to perfusion variables (n  63)
CPB (min) Aortic crossclamping (min) DHCA (min)
Spearman
correlation
coefficient P value*
Spearman
correlation
coefficient P value*
Spearman
correlation
coefficient P value*
cTnT (ng/mL)
End CPB 0.47 .001 0.49 .001 0.23 0.08
4 postoperative h 0.45 .001 0.44 .001 0.15 0.2
24 postoperative h 0.41 .001 0.37 .003 0.12 0.2
IL-6 (pg/mL)
End CPB 0.39 .003 0.34 .01 0.36 .007
4 postoperative h 0.02 .2 0.14 .2 0.10 .2
24 postoperative h 0.12 .2 0.10 .2 0.20 .20
IL-8 (pg/mL)
End CPB 0.34 .01 0.31 .02 0.28 .04
4 postoperative h 0.40 .005 0.39 .006 0.25 .09
24 postoperative h 0.25 .1 0.38 .009 0.12 .2
*Calculated by Spearman correlation coefficients.
Figure 2. Correlations between cTnT values at end of CPB with those 4 (squares, Spearman correlation coefficient
0.71, P < .001) and 24 (triangles, Spearman correlation coefficient 0.60, P < .001) hours after operation in 63
patients. All parameters are expressed by their logarithmic values.
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CPB and aortic crossclamping (tolerance 5 minutes) with
respect to the predictive value of IL-6 levels 4 hours after
the operation for the occurrence of myocardial dysfunction
was possible for 7 pairs of patients with and without myo-
cardial dysfunction. This analysis showed that IL-6 blood
levels 4 hours after the operation tended to predict myocar-
dial dysfunction within 24 hours after the operation (P 
.07, odds ratio per 10 pg/mL 1.09, 95% confidence interval
0.992-1.200).
Discussion
Myocardial Dysfunction
Our data are based on a large, homogeneous group of
consecutive term neonates with transposition of the great
Figure 3. IL-6 levels related to presence (white bars, n  11) and absence (shaded bars, n  52) of myocardial
dysfunction after CPB in 63 patients. Values expressed as mean (data points), median (horizontal lines), inter-
quartile ranges (bars), and 10th and 90th percentiles (error bars). P values represent differences between
subgroups with and without myocardial dysfunction.
Figure 4. IL-8 levels related to presence (white bars, n  11) and absence (shaded bars, n  52) of myocardial
dysfunction after CPB in 63 patients. Values expressed as mean (data points), median (horizontal lines), inter-
quartile ranges (bars), and 10th and 90th percentiles (error bars). P values represent differences between
subgroups with and without myocardial dysfunction.
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arteries in whom preoperative, perioperative, and postoper-
ative care was conducted according to standardized proto-
cols. Perioperative myocardial dysfunction was prospec-
tively evaluated by routinely available clinical examinations
as restricted pump function observed by the responsible
cardiac surgeon after coronary reperfusion and also as hy-
pocontractility of one or both ventricles assessed by quali-
tative 2-dimensional echocardiography by experienced pe-
diatric cardiologists. Standardized measurements such as
systolic shortening fraction according to m-mode echocar-
diography were not routinely available because of limited
transthoracal echolucency related to mechanical ventilation,
sternotomy, wound dressings, or pacing wires. The reliabil-
ity of our clinical criteria to evaluate myocardial dysfunc-
tion was confirmed by the fact that clinical outcome param-
eters such as AST levels, total inotropic support, delayed
sternal closure, mechanical ventilation time, and in-hospital
death were correlated with the occurrence of myocardial
dysfunction.
Release of Cardiac Troponin T
In recent studies, cTnT and cardiac troponin I have been
evaluated as indicative of perioperative myocardial damage
in adults after coronary artery bypass grafting.25,26 In pedi-
atric cardiovascular surgery, perioperative myocardial dys-
function depends on the surgical procedure itself as well as
on intraoperative factors such as durations of CPB, aortic
crossclamping, and circulatory arrest. Preliminary data in-
dicate that cTnT values shortly after surgery for congenital
heart disease are potentially useful prognostic indicators of
postoperative recovery.2-5,27 In these studies, however, data
were from children at different ages and with different types
of heart defects. Our study reports for the first time on
correlations of cTnT values with clinical outcome in a large,
homogeneous group of neonates after cardiac surgery.
Our data demonstrate that the arterial switch operation in
neonates is related to myocardial cell damage, with loss of
cTnT. In addition, our results clearly show that myocardial
dysfunction, as assessed according to our definition, is as-
sociated with higher cTnT release, suggesting a higher
degree of myocardial cell damage in these patients. On
multivariable analysis, however, cTnT elevation could not
be evaluated as an independent predictive variable of early
postoperative myocardial dysfunction in our neonatal pop-
ulation. Cardiac regulator proteins cTnT and cardiac tropo-
nin I have been accepted as specific serum markers of
irreversible cardiomyocyte injury, but it is not clear whether
they also represent a suitable marker of subtle, reversible
injury.28 The latter is suggested by a recent animal study of
our group,7 which showed that levels of circulating cardiac
troponins are not related to the percentage of necrotic or
apoptotic myocardial cells. In our study cTnT values im-
mediately after the operation were strongly correlated with
those 4 and 24 hours after CPB, probably reflecting early
release of the cytosolic component of troponin followed by
the later increase caused by slow degradation of myocardial
cell myofibrils.29
Production of the Proinflammatory Cytokines
Interleukin 6 and 8
A main purpose of this work was to assess whether en-
hanced synthesis of proinflammatory cytokines is associated
with postoperative myocardial dysfunction in neonates.
Proinflammatory cytokines are known to be mediators of
myocardial cell damage18 and have been found to be related
to postoperative damage to organs including the myocar-
dium in a recent experimental study of our group.30 Cyto-
kines are highly potent endogenous peptides capable of
modulating cardiovascular function through various mech-
anisms, such as promoting ventricular remodeling, inducing
contractile dysfunction, and uncoupling myocardial -ad-
renergic receptors.31 Tumor necrosis factor , the prototype
of harmful proinflammatory cytokines, has cytotoxic effects
leading to cell membrane damage with gap formation, rup-
ture, interstitial edema, and cell necrosis,7,32 as well as the
capability of inducing apoptosis.16 During cardiac surgery,
the myocardium has been found to be not only a target
organ for proinflammatory cytokines but also a local site of
production of circulating cytokines such as tumor necrosis
factor , IL-6, and IL-8,20,32,33 all of which are involved in
neutrophil and endothelial cell activation during CPB. In a
recent experimental study of our group, higher intramyo-
cardial tumor necrosis factor  synthesis was associated
with extensive myocardial lesions.7
In clinical studies on adults, proinflammatory cytokines
IL-6 and IL-8 were found to be associated with postopera-
tive myocardial ischemia and segmental wall abnormali-
ties18 and with the acute-phase response accompanying
myocardial infarction, reflecting the extent of early myocar-
dial damage.19,20 IL-6 was found to be produced in cardiac
myocytes during ischemia and reperfusion in patients un-
dergoing coronary bypass surgery.20 In children, IL-6 levels
were found to be elevated in the early postoperative peri-
od,11,12 correlated with the duration of inotropic support.34
IL-8 is also suggested to be produced in the ischemic
myocardium.35 In children IL-8 levels are elevated early
after cardiac surgery and are correlated with the duration of
CPB.10,13
In our homogeneous group of neonates, significant ele-
vations of IL-6 and IL-8 levels relative to preoperative
values immediately and 4 and 24 hours after surgery in
patients with and without myocardial dysfunction, and their
correlations with duration of operation variables, confirmed
the role of CPB and myocardial ischemia on the induction
of these proinflammatory cytokines. In patients with myo-
cardial dysfunction, IL-6 plasma levels tended to be higher
immediately after CPB and were significantly higher 4
hours after the operation than in those without myocardial
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dysfunction. This fact, as well as our observation of a
significant correlation between proinflammatory cytokine
levels and cTnT values in the early postoperative period,
support the assumption that proinflammatory cytokines may
contribute to myocardial damage and therefore to depressed
myocardial function.31
Limitations
The causal relationship between uncontrolled synthesis of
proinflammatory cytokines and myocardial damage and
dysfunction could only be definitively demonstrated in trials
with cytokine-blocking or -inhibiting agents. Therefore the
association between elevated plasma levels of proinflamma-
tory cytokines and myocardial dysfunction, as shown in this
study, needs to be confirmed by further investigation.
Conclusions
Cardiac operations in neonates induce the production of the
proinflammatory cytokines IL-6 and IL-8. The latter may be
related to myocardial cell damage, as indicated by cTnT
release, and to postoperative myocardial dysfunction. The
cTnT level is a useful indicator of myocardial cell damage
but does not allow prediction of the occurrence of early
postoperative myocardial dysfunction in this age group.
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